Prot #EVP-6124-017: A Multicenter 40-Week Extension Study to Evaluate the Safety and Clinical Effects of Prolonged Exposure to 1 and 2 mg Doses of EVP-6124, an Alpha-7 Nicotinic Acetylcholine Receptor Agonist, as an Adjunctive Pro-cognitive Treatment in S

Project: Research project

Project Details

Effective start/end date3/1/133/1/16


  • FORUM Pharmaceuticals Inc. (Prot #EVP-6124-017)